AI for Payer Evidence & Real-World Data Strategy
What you'll learn
- 1Use AI to design real-world evidence studies that address payer evidence gaps
- 2Apply AI to analyze payer formulary decisions and coverage policies at scale
- 3Build AI-powered tools for outcomes-based contract design and monitoring
- 4Understand how AI supports value-based pricing negotiations with evidence synthesis
# AI for Payer Evidence & Real-World Data Strategy
The gap between clinical trial evidence and payer evidence needs is widening. Trials demonstrate efficacy under controlled conditions; payers want to know about effectiveness in real-world practice, long-term outcomes beyond trial follow-up, and the economic impact of treatment decisions.
Identifying Payer Evidence Gaps
After an HTA submission or payer negotiation, companies often receive requests for additional evidence. Common payer evidence gaps include: - Long-term outcomes beyond the clinical trial follow-up period - Effectiveness in patient subgroups excluded from or underrepresented in trials - Real-world treatment persistence and adherence patterns - Healthcare resource utilization (hospitalizations, ER visits, outpatient visits) - Comparative effectiveness against treatments not studied head-to-head - Impact on indirect costs (work productivity, caregiver burden)
Payer evidence gap analysis prompt:
`
Analyze the following payer feedback and HTA outcomes for [drug name]
in [indication] across the following markets:
Unlock this lesson
Upgrade to Pro to access the full content
What you'll learn:
- Use AI to design real-world evidence studies that address payer evidence gaps
- Apply AI to analyze payer formulary decisions and coverage policies at scale
- Build AI-powered tools for outcomes-based contract design and monitoring